drug · antibody

gotistobart

Phase 3updated 3mo ago

by OncoC4 Inc🔗 ChEMBL

Phase 3

community read0 votes

Antibody drug with a maximum clinical stage of Unknown, with 1 investigational indication.

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying gotistobart

phase3ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitorsactive not recruitingn=630

News(1)

After 5-month wait, BioNTech announces Sobi CEO will take on top job at mRNA company
One of the most closely watched vacancies in biopharma has now been filled, with Sobi CEO Guido Oelkers, Ph.D., moving across to take up the top job at mRNA pioneer BioNTech.
fiercebiotech · 18d ago

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 9m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug · antibody

save

gotistobart

Phase 3updated 3mo ago

by OncoC4 Inc🔗 ChEMBL

Phase 3

community read0 votes

Antibody drug with a maximum clinical stage of Unknown, with 1 investigational indication.

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying gotistobart

phase3ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitorsactive not recruitingn=630

News(1)

After 5-month wait, BioNTech announces Sobi CEO will take on top job at mRNA company
One of the most closely watched vacancies in biopharma has now been filled, with Sobi CEO Guido Oelkers, Ph.D., moving across to take up the top job at mRNA pioneer BioNTech.
fiercebiotech · 18d ago

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 9m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

gotistobart

indications

all catalysts(0)

Trials studying gotistobart

News(1)

Report a data issue

comments(0)

gotistobart

indications

all catalysts(0)

Trials studying gotistobart

News(1)

Report a data issue

comments(0)